U/S Core Biopsy of Lymphnode (Procedure + Trucut Gun) at Dr. Essa Lab

Introduction to U/S Core Biopsy of Lymphnode (Procedure + Trucut Gun) at Dr. Essa Lab

The lymphatic system plays a critical role in the human body’s immune defense, acting as a network of nodes and vessels that filter foreign substances, fight infections, and monitor cellular health. When lymph nodes become persistently enlarged, a condition known as lymphadenopathy, clinical intervention is often required to determine the underlying cause. A U/S Core Biopsy of Lymphnode (Procedure + Trucut Gun) at Dr. Essa Lab is a highly specialized, minimally invasive diagnostic procedure designed to obtain high-quality tissue samples from an abnormal lymph node. Unlike a fine-needle aspiration (FNA), which only collects individual cells for cytological analysis, a core needle biopsy retrieves intact tissue cores. This preserves the cellular architecture of the lymph node, which is absolutely essential for accurate histopathological diagnosis, grading of malignancies, and performing advanced immunohistochemical staining.

This advanced procedure is performed under real-time ultrasound guidance. Ultrasound technology uses high-frequency sound waves to produce detailed, live images of the soft tissues, allowing the interventional radiologist to visualize the target lymph node, plan the safest needle trajectory, and avoid adjacent critical structures such as major blood vessels and nerves. The Trucut biopsy gun is a spring-loaded, automated device that rapidly advances a hollow-core needle into the lymph node to capture a clean, uncrushed tissue specimen. Dr. Essa Lab, a premier diagnostic institution in Karachi, Pakistan, combines state-of-the-art ultrasound imaging with world-class histopathology services to ensure that patients receive the most accurate, reliable, and timely diagnostic outcomes possible.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is vital to ensure safety, minimize the risk of complications, and guarantee the diagnostic quality of the biopsy sample. Patients scheduled for a U/S Core Biopsy of Lymphnode (Procedure + Trucut Gun) at Dr. Essa Lab must adhere to the following guidelines:

• Coagulation Profile: Patients must undergo blood tests, including Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), and International Normalized Ratio (INR), as well as a complete blood count (CBC) to assess platelet levels. This minimizes the risk of post-procedure bleeding.
• Medication Review: It is critical to inform the physician of all current medications. Blood thinners, anticoagulants, and antiplatelet drugs (such as aspirin, clopidogrel, warfarin, or newer oral anticoagulants) must typically be discontinued 5 to 7 days prior to the procedure, strictly under the guidance of the prescribing physician.
• Allergy History: Patients must notify the medical team of any known allergies, particularly to local anesthetics (like lidocaine), latex, skin antiseptics, or adhesive bandages.
• Dietary Instructions: While a strict fast is generally not required for superficial lymph node biopsies, patients are advised to have a light meal a few hours before the procedure. If conscious sedation is planned, fasting for 4 to 6 hours may be necessary.
• Clothing and Personal Items: Wear loose, comfortable clothing that allows easy access to the biopsy site (such as the neck, armpit, or groin). Avoid wearing jewelry or metal accessories around the area to be imaged.
• Prior Records: Bring all relevant previous diagnostic reports, including prior ultrasound scans, CT scans, PET-CT reports, and laboratory results, to assist the radiologist in targeting the correct lymph node.

During the Procedure

The U/S Core Biopsy of Lymphnode (Procedure + Trucut Gun) is performed in a dedicated, sterile interventional radiology suite. The entire process is designed to maximize patient comfort and safety while ensuring diagnostic precision:

• Patient Positioning: The patient is positioned comfortably on an examination table. Depending on the location of the target lymph node (cervical, axillary, or inguinal), the patient may lie flat on their back, slightly turned, or with their head turned to one side.
• Ultrasound Localization: The radiologist applies a sterile gel and uses a high-frequency linear ultrasound probe to locate the target lymph node, assess its depth, and map the surrounding blood vessels using color Doppler imaging.
• Sterilization and Local Anesthesia: The skin over the biopsy site is thoroughly cleansed with an antiseptic solution (such as chlorhexidine) and covered with sterile drapes. A local anesthetic (typically 1% or 2% lidocaine) is injected into the skin and subcutaneous tissues along the planned needle path. Patients may feel a brief stinging sensation during this step.
• Biopsy Execution: Once the area is completely numb, a tiny incision (approximately 1 to 2 millimeters) is made in the skin. Under continuous, real-time ultrasound visualization, the radiologist guides the Trucut biopsy needle through the incision directly into the abnormal lymph node.
• The Trucut Gun Mechanism: When the needle is perfectly positioned, the spring-loaded Trucut gun is activated. This produces a sharp, audible “click” sound as the needle quickly captures a small core of tissue. The rapid motion ensures a clean cut with minimal discomfort.
• Sample Collection: The needle is withdrawn, and the tissue core is immediately placed in a preservative solution (10% neutral buffered formalin). The radiologist typically repeats this process 2 to 4 times through the same skin nick, adjusting the angle slightly to obtain sufficient tissue from different areas of the lymph node.
• Post-Procedure Care: After the samples are secured, the needle is removed, and firm, direct pressure is applied to the biopsy site for 10 to 15 minutes to prevent bleeding and hematoma formation. A sterile adhesive bandage or pressure dressing is then applied. The patient is monitored in a recovery area for 30 to 60 minutes before being discharged.

When is a U/S Core Biopsy of Lymphnode (Procedure + Trucut Gun) Performed?

Evaluation of Suspected Lymphoproliferative Disorders (Lymphoma)

Physicians request a core needle biopsy when a patient presents with clinical signs suggestive of lymphoma, such as persistent, painless lymphadenopathy accompanied by systemic symptoms like unexplained fever, night sweats, and weight loss. Because diagnosing lymphoma requires evaluating the overall architecture of the lymph node (to distinguish between Hodgkin and various subtypes of Non-Hodgkin lymphoma), a simple fine-needle aspiration is often insufficient. The Trucut core biopsy provides intact tissue blocks that allow pathologists to perform essential immunohistochemical (IHC) profiling and flow cytometry, which are critical for selecting the correct therapeutic protocol.

Investigation of Metastatic Disease

In patients with a known history of primary malignancy (such as breast, lung, colorectal, thyroid, or head and neck cancers), the emergence of enlarged regional lymph nodes strongly suggests metastatic spread. A U/S-guided core biopsy is performed to confirm metastasis, identify the histological characteristics of the metastatic cells, and compare them with the primary tumor. This information is vital for accurate cancer staging, determining prognosis, and tailoring systemic therapies, including chemotherapy, immunotherapy, and targeted molecular treatments.

Diagnosis of Chronic Infectious and Granulomatous Diseases

In regions like Pakistan, chronic infectious diseases such as Tuberculosis (TB) are a leading cause of persistent lymphadenopathy (tuberculous lymphadenitis). A core biopsy is highly effective in detecting caseating granulomatous inflammation characteristic of TB. The retrieved tissue cores can also be sent for specialized microbiological testing, including Acid-Fast Bacilli (AFB) staining, mycobacterial culture, and GeneXpert PCR testing. It also helps differentiate TB from other granulomatous conditions like sarcoidosis or fungal infections.

Assessment of Persistent Unexplained Lymphadenopathy

When lymph nodes remain enlarged for more than four to six weeks without an obvious infectious or inflammatory cause, and do not respond to conservative medical management, a biopsy is indicated. Physicians utilize this test to rule out occult malignancies, autoimmune diseases (such as systemic lupus erythematosus or rheumatoid arthritis), and rare lymphadenopathic conditions like Castleman disease or Kikuchi-Fujimoto disease, providing a definitive diagnosis when non-invasive tests remain inconclusive.

Monitoring Treatment Response and Disease Recurrence

For patients undergoing cancer treatment, a residual or newly enlarged lymph node may represent either active residual disease, disease recurrence, or benign post-treatment changes such as necrosis and fibrosis. A U/S-guided Trucut biopsy allows clinicians to sample the tissue directly, providing definitive histological proof of whether viable tumor cells remain, which guides subsequent salvage therapies or adjustments to the treatment regimen.

What Does a U/S Core Biopsy of Lymphnode (Procedure + Trucut Gun) Detect?

The histopathological analysis of the tissue cores obtained during this procedure can detect a wide range of benign, infectious, inflammatory, and malignant conditions, including:

• Classical Hodgkin Lymphoma: Identified by the presence of characteristic Reed-Sternberg cells within an inflammatory background.
• Nodular Lymphocyte Predominant Hodgkin Lymphoma: A distinct subtype characterized by “popcorn” cells.
• Diffuse Large B-Cell Lymphoma (DLBCL): An aggressive form of Non-Hodgkin lymphoma showing sheets of large atypical B-lymphocytes.
• Follicular Lymphoma: A common indolent lymphoma displaying a nodular growth pattern of germinal center-derived cells.
• Mantle Cell Lymphoma: Characterized by monomorphic small-to-medium lymphocytes with specific cyclin D1 overexpression.
• Marginal Zone Lymphoma: A low-grade B-cell neoplasm often associated with chronic inflammation or mucosal sites.
• T-Cell Lymphomas: Various subtypes of mature T-cell malignancies characterized by atypical T-cell infiltrates.
• Metastatic Carcinoma: Presence of malignant epithelial cells originating from primary sites like the breast, lung, or gastrointestinal tract.
• Metastatic Squamous Cell Carcinoma: Frequently detected in cervical lymph nodes, originating from head and neck cancers.
• Metastatic Papillary Thyroid Carcinoma: Characterized by papillary structures, psammoma bodies, and ground-glass nuclei.
• Metastatic Melanoma: Confirmed by atypical melanocytic cells positive for S100, Melan-A, or HMB-45 markers.
• Tuberculous Lymphadenitis: Characterized by caseating granulomas, Langhans giant cells, and positive AFB staining.
• Sarcoidosis: Identified by well-formed, non-caseating granulomas without evidence of mycobacterial or fungal infection.
• Reactive Follicular Hyperplasia: A benign, reversible expansion of germinal centers in response to systemic or localized infection.
• Sinus Histiocytosis: Benign distension of lymph node sinuses by histiocytes, often seen in draining inflammatory sites.
• Suppurative Lymphadenitis: Acute bacterial infection characterized by dense neutrophilic infiltrates and abscess formation.
• Kikuchi-Fujimoto Disease: Also known as histiocytic necrotizing lymphadenitis, showing focal necrosis with abundant karyorrhectic debris.
• Rosai-Dorfman Disease: Characterized by massive sinus histiocytosis with emperipolesis (intact lymphocytes within histiocytic cytoplasm).
• Toxoplasma Lymphadenitis: Showing a triad of follicular hyperplasia, epithelioid histiocytes, and monocytoid B-cell hyperplasia.
• Cat Scratch Disease: Displaying necrotizing granulomas with microabscesses, caused by Bartonella henselae.
• Amyloidosis: Deposition of amorphous, extracellular eosinophilic material that shows apple-green birefringence under polarized light with Congo red stain.
• Dermatopathic Lymphadenitis: A benign response to chronic skin diseases, showing paracortical expansion with dendritic cells and melanin-laden macrophages.
• Metastatic Lobular Breast Carcinoma: Characterized by single-file infiltration of tumor cells (targetoid pattern) within the lymph node.
• Small Lymphocytic Lymphoma (SLL): Tissue manifestation of chronic lymphocytic leukemia, showing diffuse sheets of small, mature-appearing lymphocytes.
• Anaplastic Large Cell Lymphoma (ALCL): An aggressive T-cell lymphoma characterized by hallmark cells and strong CD30 positivity.

Turnaround Time and Report Access at Dr. Essa Lab

At Dr. Essa Lab, we understand that waiting for biopsy results can be an anxious time for patients and their families. The processing of a core tissue biopsy is a meticulous, multi-step laboratory procedure. Once the tissue cores are collected, they undergo fixation in formalin to preserve cellular structures, followed by dehydration, paraffin embedding, microtome sectioning, and staining with Hematoxylin and Eosin (H&E). This standard histopathological process typically takes 3 to 5 working days.

If the initial evaluation suggests a complex malignancy or lymphoma, our expert pathologists will perform Immunohistochemistry (IHC) to identify specific cellular markers. IHC testing is crucial for precise tumor typing but may extend the reporting time by an additional 2 to 3 days. Dr. Essa Lab offers seamless report access; patients receive an SMS notification as soon as the report is finalized. Reports can be viewed and downloaded online via the official Dr. Essa Lab patient portal or mobile application, or physically collected from any of our conveniently located diagnostic centers across Karachi and Pakistan.

U/S Core Biopsy of Lymphnode (Procedure + Trucut Gun) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Lymph Node Architecture	Intact cortex, paracortex, and medulla; preserved subcapsular and medullary sinuses.	Effaced or distorted architecture; nodular or diffuse sheets of atypical cells replacing normal structures.
Cellular Composition	Polymorphous population of mature lymphocytes, plasma cells, and histiocytes.	Monomorphous population of atypical lymphoid cells; presence of Reed-Sternberg cells or foreign epithelial cells.
Granulomas & Necrosis	Absent; no necrotic debris or granulomatous inflammation.	Caseating granulomas (Tuberculosis); non-caseating granulomas (Sarcoidosis); focal or confluent necrosis.
Metastatic Infiltration	No foreign epithelial, melanocytic, or mesenchymal cells detected.	Clusters or sheets of metastatic carcinoma, melanoma, or sarcoma cells.
Capsular Integrity	Intact, thin fibrous capsule surrounding the lymph node without invasion.	Infiltration of malignant cells through the capsule into surrounding adipose and soft tissues.
Vascularity	Normal hilar vascularity; no atypical angiogenesis or vascular invasion.	Increased, disorganized vascularity; tumor emboli within lymphatic or blood vessels.
Special Stains (AFB / PAS)	Negative for acid-fast bacilli and fungal organisms.	Positive AFB (Mycobacterium tuberculosis); positive PAS or Grocott’s methenamine silver (fungal elements).
Immunohistochemistry (IHC)	Normal distribution of B-cells (CD20+) and T-cells (CD3+) matching normal histology.	Aberrant antigen expression; monoclonal light chain restriction (kappa/lambda); strong positivity for tumor-specific markers (e.g., CK, GATA3, TTF-1).

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for U/S Core Biopsy of Lymphnode (Procedure + Trucut Gun)?

• Experienced Healthcare Professionals: Our interventional radiologists possess extensive expertise in performing precise ultrasound-guided biopsies, minimizing patient discomfort and maximizing diagnostic yield.
• Advanced Pathology Infrastructure: Dr. Essa Lab features a state-of-the-art histopathology department staffed by highly qualified consultant pathologists specializing in oncopathology and immunohistochemistry.
• High-Resolution Ultrasound Technology: We utilize modern ultrasound systems equipped with high-frequency linear probes and advanced color Doppler to ensure precise needle placement and avoid vascular structures.
• Strict Safety Protocols: The procedure is performed under stringent sterile conditions, adhering to international infection control and patient safety standards.
• Comprehensive Diagnostic Integration: From initial ultrasound imaging to final histopathological and molecular analysis, the entire diagnostic pathway is managed seamlessly under one roof.
• Patient-Focused Care: We prioritize patient comfort, offering detailed pre-procedure counseling, gentle procedural techniques, and dedicated post-procedure monitoring.
• Convenient Report Access: Patients can easily access their diagnostic reports online through our secure web portal or mobile app, reducing the need for unnecessary travel.
• Decades of Trust: Dr. Essa Lab is one of Pakistan’s most trusted diagnostic networks, recognized for its commitment to clinical accuracy, quality, and ethical medical practices.